Literature DB >> 34387805

Introduction to novel developments in radio-imaging and radiotherapy.

Baldassarre Stea1,2, Russell S Witte3,4.   

Abstract

Radiation therapy has long been known to be a very effective form of therapy in relieving symptoms and prolonging the life of patients with brain metastases. Novel developments in this field have allowed oncologists to improve on older forms of radiation therapy; these recent advances in radiotherapeutic techniques (stereotactic radiosurgery and hippocampal-avoidant whole brain radiation therapy) allow sparing of the healthy brain from receiving unnecessary radiation while delivering effective treatment to the metastases, thus improving the quality of life for surviving patients. Furthermore, multiple clinical trials have documented the increased loco-regional control in the brain when radiosurgery is interdigitated with immune check point inhibitors for treatment of melanoma brain metastases. Mild hyperthermia has been used for decades as an adjuvant to radiotherapy in the treatment of radiation resistant cancers; lately, however, thermal therapies, such as hyperthermia, cryoablation, radiofrequency ablation and high intensity focused ultrasound are being investigated to provide a new ablative approach to cancer while thermoacoustic imaging and thermometry have recently been proposed as new techniques for monitoring tissue temperature in the breast during ablation treatment. In addition, other hybrid techniques have emerged that combine ultrasounds with other forms of energy such as light to provide a more accurate diagnosis and enhance the efficacy of therapy for early and late stage cancers.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Brain metastases; Focused microwave therapy; Hyperthermia; Immune check point inhibitors; Non-invasive treatment of tumors; Stereotactic radiosurgery; Thermo-acoustic imaging; Tumors radiosensitivity

Mesh:

Year:  2021        PMID: 34387805     DOI: 10.1007/s10585-021-10114-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Authors:  Martin Kocher; Riccardo Soffietti; Ufuk Abacioglu; Salvador Villà; Francois Fauchon; Brigitta G Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Sandra Collette; Laurence Collette; Rolf-Peter Mueller
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

Review 2.  The role of radiation therapy in the treatment of metastatic cancer.

Authors:  Baldassarre Stea; Tijana Skrepnik; Charles C Hsu; Roy Abendroth
Journal:  Clin Exp Metastasis       Date:  2018-07-30       Impact factor: 5.150

3.  Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.

Authors:  Blair Murphy; Joshua Walker; Solange Bassale; Debra Monaco; Jerry Jaboin; Jeremy Ciporen; Matthew Taylor; Charlotte Dai Kubicky
Journal:  Am J Clin Oncol       Date:  2019-03       Impact factor: 2.339

4.  Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Authors:  Paul D Brown; Karla V Ballman; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Anthony C Whitton; Jeffrey Greenspoon; Ian F Parney; Nadia N I Laack; Jonathan B Ashman; Jean-Paul Bahary; Costas G Hadjipanayis; James J Urbanic; Fred G Barker; Elana Farace; Deepak Khuntia; Caterina Giannini; Jan C Buckner; Evanthia Galanis; David Roberge
Journal:  Lancet Oncol       Date:  2017-07-04       Impact factor: 41.316

5.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Authors:  Paul D Brown; Kurt Jaeckle; Karla V Ballman; Elana Farace; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Fred G Barker; Richard Deming; Stuart H Burri; Cynthia Ménard; Caroline Chung; Volker W Stieber; Bruce E Pollock; Evanthia Galanis; Jan C Buckner; Anthony L Asher
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

6.  Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Authors:  Linda Chen; Jacqueline Douglass; Lawrence Kleinberg; Xiaobu Ye; Ariel E Marciscano; Patrick M Forde; Julie Brahmer; Evan Lipson; William Sharfman; Hans Hammers; Jarushka Naidoo; Chetan Bettegowda; Michael Lim; Kristin J Redmond
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-05       Impact factor: 7.038

7.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

Review 8.  Cancer heterogeneity and metastasis: life at the edge.

Authors:  Robert J Gillies
Journal:  Clin Exp Metastasis       Date:  2021-05-17       Impact factor: 5.150

9.  Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Authors:  Paul D Brown; Vinai Gondi; Stephanie Pugh; Wolfgang A Tome; Jeffrey S Wefel; Terri S Armstrong; Joseph A Bovi; Cliff Robinson; Andre Konski; Deepak Khuntia; David Grosshans; Tammie L S Benzinger; Deborah Bruner; Mark R Gilbert; David Roberge; Vijayananda Kundapur; Kiran Devisetty; Sunjay Shah; Kenneth Usuki; Bethany Marie Anderson; Baldassarre Stea; Harold Yoon; Jing Li; Nadia N Laack; Tim J Kruser; Steven J Chmura; Wenyin Shi; Snehal Deshmukh; Minesh P Mehta; Lisa A Kachnic
Journal:  J Clin Oncol       Date:  2020-02-14       Impact factor: 50.717

Review 10.  Role of radiation oncology in modern multidisciplinary cancer treatment.

Authors:  Vincenzo Valentini; Luca Boldrini; Silvia Mariani; Mariangela Massaccesi
Journal:  Mol Oncol       Date:  2020-06-22       Impact factor: 6.603

View more
  1 in total

1.  Introduction: Novel Frontiers in Cancer Metastasis.

Authors:  Stanley P Leong; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2022-02-22       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.